EPHA5
Basic information
Region (hg38): 4:65319563-65670495
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EPHA5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 35 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 2 | 3 |
Variants in EPHA5
This is a list of pathogenic ClinVar variants found in the EPHA5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-65324128-T-A | not specified | Uncertain significance (Apr 05, 2023) | ||
4-65324131-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
4-65324191-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
4-65332106-G-C | not specified | Uncertain significance (Aug 03, 2022) | ||
4-65335965-C-T | not specified | Uncertain significance (Jun 02, 2024) | ||
4-65348065-T-A | not specified | Uncertain significance (Jan 08, 2024) | ||
4-65348113-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
4-65348188-T-C | not specified | Uncertain significance (May 05, 2023) | ||
4-65353038-C-T | Benign (Jun 18, 2018) | |||
4-65353065-C-A | not specified | Uncertain significance (Sep 01, 2021) | ||
4-65365009-A-T | Benign (Oct 10, 2018) | |||
4-65365052-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
4-65365176-G-A | not specified | Uncertain significance (Apr 08, 2022) | ||
4-65365187-A-G | not specified | Uncertain significance (Mar 30, 2024) | ||
4-65365956-T-A | not specified | Uncertain significance (Oct 22, 2021) | ||
4-65365965-A-T | Likely benign (Jun 01, 2018) | |||
4-65365975-C-A | not specified | Uncertain significance (Aug 20, 2023) | ||
4-65365981-A-G | Benign (Jul 15, 2018) | |||
4-65367367-A-T | not specified | Uncertain significance (Mar 02, 2023) | ||
4-65367417-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
4-65377059-A-C | not specified | Uncertain significance (Feb 10, 2023) | ||
4-65404419-C-T | Lung adenocarcinoma | Likely pathogenic (May 13, 2016) | ||
4-65414389-C-G | Benign (May 18, 2018) | |||
4-65414400-G-A | not specified | Uncertain significance (Mar 03, 2022) | ||
4-65420545-C-T | not specified | Uncertain significance (Apr 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EPHA5 | protein_coding | protein_coding | ENST00000273854 | 18 | 350933 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000729 | 1.00 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.36 | 475 | 566 | 0.839 | 0.0000299 | 6763 |
Missense in Polyphen | 200 | 283.69 | 0.70501 | 3401 | ||
Synonymous | -1.34 | 228 | 204 | 1.12 | 0.0000111 | 2009 |
Loss of Function | 4.16 | 16 | 46.6 | 0.343 | 0.00000229 | 599 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000279 | 0.000279 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.000238 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000892 | 0.0000879 |
Middle Eastern | 0.000238 | 0.000217 |
South Asian | 0.0000331 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI- anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 most probably constitutes the cognate/functional ligand for EPHA5. Functions as an axon guidance molecule during development and may be involved in the development of the retinotectal, entorhino- hippocampal and hippocamposeptal pathways. Together with EFNA5 plays also a role in synaptic plasticity in adult brain through regulation of synaptogenesis. In addition to its function in the nervous system, the interaction of EPHA5 with EFNA5 mediates communication between pancreatic islet cells to regulate glucose- stimulated insulin secretion (By similarity). {ECO:0000250}.;
- Pathway
- Axon guidance - Homo sapiens (human);Developmental Biology;EPH-Ephrin signaling;Ephrin A reverse signaling;Axon guidance;EPHA forward signaling
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.594
- rvis_EVS
- -1.24
- rvis_percentile_EVS
- 5.49
Haploinsufficiency Scores
- pHI
- 0.293
- hipred
- Y
- hipred_score
- 0.737
- ghis
- 0.577
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.588
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Epha5
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- transmembrane receptor protein tyrosine kinase signaling pathway;axon guidance;peptidyl-tyrosine phosphorylation;cAMP-mediated signaling;hippocampus development;positive regulation of CREB transcription factor activity;regulation of actin cytoskeleton organization;regulation of GTPase activity;ephrin receptor signaling pathway;neuron development;regulation of insulin secretion involved in cellular response to glucose stimulus
- Cellular component
- rough endoplasmic reticulum;plasma membrane;integral component of plasma membrane;external side of plasma membrane;axon;dendrite;neuron projection;neuronal cell body;receptor complex;perinuclear region of cytoplasm
- Molecular function
- transmembrane receptor protein tyrosine kinase activity;ephrin receptor activity;GPI-linked ephrin receptor activity;transmembrane-ephrin receptor activity;ATP binding